Evidence mapPaperPMID 40325232Full record

ArticleWorld journal of microbiology & biotechnology2025

Targeted inhibition of E. coli adhesion using antisense oligonucleotides: an approach to combat bacteria via CsrB targeting.

Fatemeh Naderi Noukabadi, Mohammad Ali Shokrgozar, Mana Oloomi

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fatemeh Naderi NoukabadiDepartment of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Mohammad Ali ShokrgozarNational Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran.
Mana OloomiMolecular Biology Department, Pasteur Institute of Iran Tehran, Tehran, 13169-43551, Iran. manaoloomi@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm is the most prevalent form of bacterial existence in natural environments and is associated with serious health conditions such as diarrhea and kidney failure. The carbon storage regulator A (CsrA) protein, along with its small regulatory RNAs CsrB and CsrC, plays a pivotal role in key cellular processes, including biofilm formation, motility, carbon metabolism, iron homeostasis, and stress response. In this study, a novel antisense oligonucleotide (ASO) was specifically designed to target and silence the csrB gene in Escherichia coli. The ASO was delivered using polyethyleneimine (PEI), and its efficacy was evaluated through gene expression analysis, colony-forming unit (CFU) assays, and crystal violet staining. Quantitative real-time PCR revealed a significant reduction in csrB and csrA expression in the treated O42 strain (p = 0.004 and p = 0.013, respectively), as well as a notable decrease in csrB expression in the O157 strain (p = 0.041). Furthermore, biofilm formation and bacterial adhesion were significantly reduced in the treated O42 strain (p = 0.046 and p = 0.028, respectively). These findings suggest that antisense oligonucleotides targeting small regulatory RNAs such as csrB may offer a promising therapeutic strategy for controlling biofilm-associated infections by disrupting key regulatory pathways in bacterial adhesion and biofilm development.

Indexed as

Bacterial AdhesionEscherichia coliEscherichia coli ProteinsOligonucleotides, AntisenseRepressor ProteinsRNA-Binding ProteinsBiofilmsGene Expression Regulation, BacterialCsrA protein, E coliEscherichia coli ProteinsOligonucleotides, AntisenseRepressor ProteinsRNA-Binding ProteinsAntisense oligonucleotidesCarbon storage regulator A (CsrA)CsrBEscherichia coliPolyethyleneimine (PEI)

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.